Alerts will be sent to your verified email
Verify Email
VENMAX
|
Venmax Drugs&Pharma
|
Adeshwar Meditex
|
Ishita Drugs & Inds.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.17 % | 5.67 % | 8.38 % |
|
5yr average Equity Multiplier
|
0.08 | 2.23 | 1.27 |
|
5yr Average Asset Turnover Ratio
|
0.14 | 1.12 | 1.23 |
|
5yr Avg Net Profit Margin
|
-19.62 % | 2.25 % | 5.43 % |
|
Price to Book
|
2.33 | 0.6 | 2.14 |
|
P/E
|
25.09 | 10.69 | 27.1 |
|
5yr Avg Cash Conversion Cycle
|
288.55 Days | 157.84 Days | 74.52 Days |
|
Inventory Days
|
5.2 Days | 119.5 Days | 35.08 Days |
|
Days Receivable
|
430.69 Days | 131.36 Days | 31.6 Days |
|
Days Payable
|
141.12 Days | 99.91 Days | 42.7 Days |
|
5yr Average Interest Coverage Ratio
|
-260.56 | 2.29 | 24.46 |
|
5yr Avg ROCE
|
-47.43 % | 12.9 % | 11.48 % |
|
5yr Avg Operating Profit Margin
|
-65.91 % | 6.1 % | 6.66 % |
|
5 yr average Debt to Equity
|
-0.45 | 0.59 | 0.09 |
|
5yr CAGR Net Profit
|
-42.57 % | 4.26 % | 0.95 % |
|
5yr Average Return on Assets
|
199.45 % | 2.58 % | 6.68 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
15.14 % | 57.55 % | 50.04 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-7.99 % | -0.9 % | 0.72 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Venmax Drugs&Pharma
|
Adeshwar Meditex
|
Ishita Drugs & Inds.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|